The Thiopurine Tale: An Unexpected Journey
- PMID: 35024806
- DOI: 10.1093/ecco-jcc/jjac004
The Thiopurine Tale: An Unexpected Journey
Abstract
Exactly 70 years ago [1951] mercaptopurine was discovered by Gertrude Elion as a novel treatment option for acute leukaemia. A total of three thiopurines (also thioguanine [1950] and azathioprine [1957]) were developed over time. These immunosuppressive drugs were also successfully introduced a few decades later to prevent rejection of transplanted organs and to treat several autoimmune diseases. For her discovery of thiopurines and other antimetabolite drugs, in 1988 Elion was rewarded, together with George Hitchings and James Black, with the Nobel Prize in Physiology or Medicine. Important steps have been made in recent years to unravel its metabolism, mode of action and pharmacogenetics. Today thiopurine [based] therapy remains an essential immunosuppressive approach in treating patients with inflammatory bowel disease.
Keywords: Thiopurines; inflammatory bowel disease.
© The Author(s) 2022. Published by Oxford University Press on behalf of European Crohn’s and Colitis Organisation. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.J Crohns Colitis. 2018 Apr 27;12(5):610-620. doi: 10.1093/ecco-jcc/jjx181. J Crohns Colitis. 2018. PMID: 29293971 Review.
-
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety.Clin Gastroenterol Hepatol. 2004 Sep;2(9):731-43. doi: 10.1016/s1542-3565(04)00344-1. Clin Gastroenterol Hepatol. 2004. PMID: 15354273 Review.
-
Optimizing treatment with thioguanine derivatives in inflammatory bowel disease.Best Pract Res Clin Gastroenterol. 2003 Feb;17(1):37-46. doi: 10.1053/bega.2002.0346. Best Pract Res Clin Gastroenterol. 2003. PMID: 12617881 Review.
-
Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.Aliment Pharmacol Ther. 2012 Jan;35(1):15-36. doi: 10.1111/j.1365-2036.2011.04905.x. Epub 2011 Nov 2. Aliment Pharmacol Ther. 2012. PMID: 22050052 Review.
-
Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.Dig Liver Dis. 2008 Jun;40(6):425-32. doi: 10.1016/j.dld.2008.01.003. Epub 2008 Mar 4. Dig Liver Dis. 2008. PMID: 18304898 Clinical Trial.
Cited by
-
Early proactive monitoring of DNA-thioguanine in patients with Crohn's disease predicts thiopurine-induced late leucopenia in NUDT15/TPMT normal metabolizers.World J Gastroenterol. 2024 Mar 28;30(12):1751-1763. doi: 10.3748/wjg.v30.i12.1751. World J Gastroenterol. 2024. PMID: 38617736 Free PMC article. Clinical Trial.
-
Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care.Indian J Gastroenterol. 2024 Feb;43(1):36-47. doi: 10.1007/s12664-024-01529-x. Epub 2024 Feb 21. Indian J Gastroenterol. 2024. PMID: 38383877 Free PMC article. Review.
-
Cyanothioacetamides as a synthetic platform for the synthesis of aminopyrazole derivatives.Beilstein J Org Chem. 2023 Aug 8;19:1191-1197. doi: 10.3762/bjoc.19.87. eCollection 2023. Beilstein J Org Chem. 2023. PMID: 37592935 Free PMC article.
-
6-Thioguanosine Monophosphate Prodrugs Display Enhanced Performance against Thiopurine-Resistant Leukemia and Breast Cancer Cells.J Med Chem. 2022 Nov 24;65(22):15165-15173. doi: 10.1021/acs.jmedchem.2c01010. Epub 2022 Nov 14. J Med Chem. 2022. PMID: 36374020 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources